Aprogen Biologics Inc. (KRX:003060)
South Korea
· Delayed Price · Currency is KRW 283.00
+6.00 (2.17%)
At close: Mar 10, 2026
Aprogen Biologics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 55,716 | 130,793 | 190,684 | 200,481 | 360,706 | 524,120 | Upgrade
|
| Market Cap Growth | -58.53% | -31.41% | -4.89% | -44.42% | -31.18% | 60.07% | Upgrade
|
| Enterprise Value | 271,751 | 176,792 | 383,113 | 209,570 | 302,520 | 379,267 | Upgrade
|
| Last Close Price | 282.00 | 662.00 | 2203.94 | 3822.70 | 6877.82 | 9993.74 | Upgrade
|
| PE Ratio | - | - | - | 15.86 | 44.52 | 46.58 | Upgrade
|
| PS Ratio | 0.74 | 1.94 | 2.18 | 3.08 | 6.39 | 9.83 | Upgrade
|
| PB Ratio | 0.18 | 0.35 | 0.52 | 0.39 | 0.60 | 0.88 | Upgrade
|
| P/TBV Ratio | 0.23 | 0.35 | 0.53 | 0.48 | 0.71 | 1.04 | Upgrade
|
| P/FCF Ratio | - | - | - | 8.20 | - | 73.70 | Upgrade
|
| P/OCF Ratio | - | - | - | 7.79 | - | 64.80 | Upgrade
|
| EV/Sales Ratio | 3.63 | 2.62 | 4.39 | 3.22 | 5.36 | 7.11 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | - | 445.50 | Upgrade
|
| EV/FCF Ratio | -5.04 | - | - | 8.57 | - | 53.33 | Upgrade
|
| Debt / Equity Ratio | 0.61 | 0.41 | 0.49 | 0.26 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | - | 3.49 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 5.51 | - | 0.42 | Upgrade
|
| Net Debt / Equity Ratio | 0.46 | 0.31 | 0.46 | 0.07 | -0.20 | -0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.65 | -2.93 | -3.47 | -19.81 | 64.35 | -237.40 | Upgrade
|
| Net Debt / FCF Ratio | -2.68 | -2.50 | -2.77 | 1.46 | 17.44 | -28.42 | Upgrade
|
| Asset Turnover | 0.12 | 0.11 | 0.14 | 0.10 | 0.09 | 0.11 | Upgrade
|
| Inventory Turnover | 1.85 | 1.50 | 1.98 | 1.25 | 3.09 | 3.25 | Upgrade
|
| Quick Ratio | 0.32 | 0.38 | 0.17 | 0.75 | 15.45 | 25.69 | Upgrade
|
| Current Ratio | 0.86 | 0.78 | 0.54 | 1.49 | 37.41 | 38.79 | Upgrade
|
| Return on Equity (ROE) | -51.80% | -28.09% | -26.24% | 2.46% | 1.53% | 4.00% | Upgrade
|
| Return on Assets (ROA) | -10.83% | -6.20% | -6.94% | -0.40% | -0.40% | -0.14% | Upgrade
|
| Return on Invested Capital (ROIC) | -22.55% | -11.33% | -13.02% | -0.75% | -0.85% | -0.33% | Upgrade
|
| Return on Capital Employed (ROCE) | -27.30% | -13.20% | -16.40% | -0.80% | -0.70% | -0.20% | Upgrade
|
| Earnings Yield | -348.71% | -80.26% | -62.02% | 6.30% | 2.25% | 2.15% | Upgrade
|
| FCF Yield | -96.73% | -35.37% | -32.38% | 12.19% | -1.95% | 1.36% | Upgrade
|
| Buyback Yield / Dilution | -113.09% | -99.40% | -56.07% | -1.42% | -25.52% | -94.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.